{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-000454","form_type":"8-K","ticker":"ZSQR","cik":"0001759186","company_name":"Z Squared Inc.","filed_at":"2023-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.436536+00:00","generated_at":"2026-06-20T05:34:34.795136+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Coeptis enters sponsored research agreement with Univ. of Pittsburgh for SNAP-CAR HER2 pre-clinical work","bullets":["Sponsored research agreement with University of Pittsburgh to advance SNAP-CAR T cells targeting HER2-positive cancers.","Pre-clinical work will support IND filing for clinical trials, initially targeting ovarian cancer.","Research led by Dr. Lohmueller and Dr. Deiters; IQVIA to assist as CRO for lead candidate selection.","HER2 overexpressed in ~28% of ovarian cancer and ~25% of breast cancer cases, per the press release."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-000454","json":"https://secwatch.observer/filing/0001683168-23-000454.json","markdown":"https://secwatch.observer/filing/0001683168-23-000454.md","text":"https://secwatch.observer/filing/0001683168-23-000454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759186/000168316823000454/0001683168-23-000454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759186/000168316823000454/coeptis_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T05:34:34.795136+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}